INSMED: Pay

INSMED paid its 5 named executives $32.6M in total in FY2025 (Dec). CEO William H. Lewis was paid $14.5M of that.

Pay$100 in the stock at the end of FY20 → $523
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

William H. LewisCEO
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Martina Flammer, M.D.Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Roger AdsettChief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Sara BonsteinChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Michael A. SmithChief Legal Officer6
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years

CEO pay against the pay peers

No CEO pay of the disclosed peers is on file for FY2023 (Dec).

  1. 1INSMED
  2. 2Acadia Pharmaceuticals Inc.Not disclosed
  3. 3Agios Pharmaceuticals, Inc.Not disclosed
  4. 4Amicus Therapeutics, Inc.Not disclosed
  5. 5Arrowhead PharmaceuticalsNot disclosed
  6. 6Blueprint MedicinesNot disclosed
  7. 7Corcept Therapeutics IncorporatedNot disclosed
  8. 8Editas Medicine, Inc.Not disclosed
  9. 9Halozyme Therapeutics, Inc.Not disclosed
  10. 10Intercept Pharmaceuticals, Inc.Not disclosed
  11. 11Nektar TherapeuticsNot disclosed
  12. 12PTC Therapeutics, Inc.Not disclosed
  13. 13Sangamo Therapeutics, Inc.Not disclosed
  14. 14Sarepta Therapeutics, Inc.Not disclosed
  15. 15Ultragenyx Pharmaceutical Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.